IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) resistance through endoplasmic reticulum stress signaling pathway in triple negative breast cancer cells
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE171641
下载链接
链接失效反馈官方服务：
资源简介：
We investigated how gefitinib-treatment and/or IL-26 stimulation affected gene expression in HCC70 cells by DNA microarray analysis. Human breast carcinoma cell lines HCC70 were treated with media as a gefitinib or IL-26 for 3 hr, and total RNA was isolated for a total of 4 samples.
创建时间：
2021-06-08
